Fredrik Öberg
Chief Tech/Sci/R&D Officer at MEDIVIR AB
Net worth: 151 086 $ as of 2024-03-30
Network origin in Fredrik Öberg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
50
| Public Company | Pharmaceuticals: Major | 50 |
DNB Asset Management AS (Sweden)
 DNB Asset Management AS (Sweden) Investment ManagersFinance DNB Asset Management AS (Sweden) (DNBAM) is the wholly-owned Swedish subsidiary of E. Ohman J :or Fonder AB, ultimately held by the Dinkelspiel family's E. Ohman J :or AB is Sweden. The group was established in 1990 when Bergen Bank and Den norske Creditbank merged. Also known as Carlson Investment Management, DNBAM was established in 1990 and is located in Stockholm. Research and portfolio management is shared internationally within the asset management division of the DNB group, which comprises fellow subsidiaries in Oslo, New York, Hong Kong and London. DNBAM manages mutual funds, hedge funds and discretionary portfolios for corporate and institutional clients in Norway and Sweden including pension funds. Their clientele also includes family offices and high-net worth individuals. The firm is committed to ethical investment and avoids investing in companies involved in the production, stockpiling and sales of anti-personnel mines or cluster weapons.
27
| Extinct | Investment Managers | 27 |
Skandinaviska Enskilda Banken AB (Private Banking)
 Skandinaviska Enskilda Banken AB (Private Banking) Investment ManagersFinance Skandinaviska Enskilda Banken AB (Private Banking) (SEB-PB) is the private banking division of Skandinaviska Enskilda Banken AB (ST: SEB) in Sweden. Created in 2007 when SEB Asset Management merged with their private banking business, the firm provides asset management and private banking services to institutions, high-net worth individuals and retail clients from the Nordic countries, the Baltics, Germany, Luxembourg and Poland. Located in Stockholm, the firm has additional offices in the Nordic countries, the Baltics, England, Germany, Luxembourg, Poland, Singapore and Switzerland and has representative offices in France and Spain. SEB-PB offers a full spectrum of wealth management expertise and services, including equity, fixed-income, alternative products, as well as packaging and sales of mutual funds and institutional portfolios.
12
| Operating Division | Investment Managers | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Fredrik Öberg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Chief Executive Officer Director/Board Member Chairman Director of Finance/CFO | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SEB Investment Management AB
 SEB Investment Management AB Investment ManagersFinance SEB Investment Management AB (SEB IM) is an investment management firm headquartered in Stockholm, Sweden. The firm was founded in 1978 and is a wholly-owned subsidiary of Skandinaviska Enskilda Banken AB (STO: SEB-A, ADR: SKVKY). SEB-IM offers a broad range of funds and tailored portfolios for institutional investors as well as retail and private banking clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities | |
E. Öhman J :or Fonder AB
 E. Öhman J :or Fonder AB Investment ManagersFinance E. Öhman J:or Fonder AB (Öhman Fonder) is the wholly-owned fund management subsidiary of E. Öhman J:or Asset Management AB, itself a subsidiary of the Dinkelspeil family's E. Öhman J:or AB in Sweden. Formerly known as SalusAnsvar E Öhman Fonder, the firm was founded in 1947 and became E. Öhman J:or Fonder AB in 2005. Headquartered in Stockholm, Öhman Fonder offers fund management and discretionary portfolio management to institutions, insurance companies and wealthy individuals. | Investment Managers | Portfolio Manager-Equities Head-Equity Investments Head-Equity Investments Chief Executive Officer Portfolio Manager-Equities Head-Equity Investments Trading-Equity Portfolio Manager-Equities | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ENEA AB | Packaged Software | Director/Board Member Director of Finance/CFO | |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Director/Board Member Chairman | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Chief Executive Officer General Counsel Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Comptroller/Controller/Auditor | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| CELLAVISION AB | Medical Specialties | Director/Board Member Director/Board Member | |
| OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| REJLERS AB | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MEDCAP AB | Medical Specialties | Chairman Chairman Director/Board Member | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Investor Relations Contact Chairman | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| ATTANA AB | Medical/Nursing Services | Chairman Director/Board Member | |
Cross Pharma AB
 Cross Pharma AB Medical DistributorsDistribution Services Part of Unimedic AB, Cross Pharma AB is a supplier of medical equipment. The private company is based in Stockholm, Sweden. The Swedish company was founded by Karl Johan Kristian Perlhagen. Cross Pharma was acquired by Unimedic AB from Medivir AB on June 30, 2013 for $2.91 million. | Medical Distributors | Director/Board Member Chief Executive Officer | |
| Royal Institute of Technology | College/University | Anna Yvonne Monica Malm Bernsten | Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree |
| University of Lund | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| Umea Universitet | College/University | Doctorate Degree Undergraduate Degree | |
Nordea Bank ABP (Broker)
 Nordea Bank ABP (Broker) Investment Banks/BrokersFinance Nordea Bank ABP (Broker) (Nordea Bank-Broker) is the Sweden-based broker/dealer division of Nordea Bank ABP (HEL: NDA-FI; OTCMKTS: NRDBY) in Finland. Headquartered in Stockholm, Nordea Bank-Broker was founded in 2001 and provides trading and execution services to various types of investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| OxyPharma AB | Director/Board Member Director/Board Member Chairman | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| MENDUS AB | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| Linköping Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| G. Pettersson & Partners AB | Director/Board Member Director/Board Member | ||
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer Director/Board Member | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Director of Finance/CFO Chief Executive Officer | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Medivir Personal AB | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | ||
| Glycovisc BioTech AB | Director/Board Member Corporate Officer/Principal Director/Board Member |
Statistics
International
| Sweden | 49 |
| United Kingdom | 2 |
| Denmark | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 4 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 380 |
| Chairman | 146 |
| Corporate Officer/Principal | 112 |
| Independent Dir/Board Member | 90 |
| Chief Executive Officer | 73 |
Most connected contacts
- Stock Market
- Insiders
- Fredrik Öberg
- Company connections
